{"transactions":[{"id":677993,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2026-08-24T23:04:14.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":762,"price":78,"value":59436.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates."}],"balance_after":28554,"source":{"system":"sec-edgar","filing":"0001193125-26-363888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312526363888/ownership.xml","form_type":"4"}},{"id":731146,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2026-06-22T20:57:59.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":762,"price":62.24,"value":47426.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,436 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates."}],"balance_after":29316,"source":{"system":"sec-edgar","filing":"0001193125-26-277646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312526277646/ownership.xml","form_type":"4"}},{"id":847267,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2026-03-12T20:41:09.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":662,"price":78.86,"value":52205.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported ($78.86) is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $78.82 to $79.82 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,384 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates."}],"balance_after":30078,"source":{"system":"sec-edgar","filing":"0001193125-26-104315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312526104315/ownership.xml","form_type":"4"}},{"id":849601,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2026-03-11T20:38:49.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":1,"price":78.52,"value":78.52,"ownership":{"direct":false,"nature":"Reeve Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-102296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312526102296/ownership.xml","form_type":"4"}},{"id":849600,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2026-03-11T20:38:49.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":1807,"price":82.25,"value":148625.75,"ownership":{"direct":false,"nature":"Reeve Trust"},"balance_after":1,"source":{"system":"sec-edgar","filing":"0001193125-26-102296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312526102296/ownership.xml","form_type":"4"}},{"id":882797,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:42:51.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 quarterly installments of 624 shares vesting beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each year 2026, 2027, 2028, and 2029 and 640 shares vesting on March 6, 2030, if he still employed by the Company as of those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,348 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,964 shares will vest on March 6, 2026; 1,948 shares will vest on each of May 20, 2026, August 20, 2026, November 20, 2026; 1,956 shares will vest on March 6, 2027;  1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 1,640 shares will vest on March 6, 2028; 1,130 shares will vest on each of May 20, 2028, August 20, 2028, November 20, 2028; 1,134 shares will vest on March 6, 2029; 624 shares will vest on each of May 20, 2029, August 20, 2029,  November 20, 2029 and the remaining 640 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date."}],"balance_after":30740,"source":{"system":"sec-edgar","filing":"0001193125-26-072703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312526072703/ownership.xml","form_type":"4"}},{"id":989331,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2025-11-25T21:08:03.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":743,"price":71.01,"value":52760.43,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported $71.01 is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $71.01  to $71.31 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,348 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates."}],"balance_after":20740,"source":{"system":"sec-edgar","filing":"0001193125-25-297192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312525297192/ownership.xml","form_type":"4"}},{"id":1059660,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2025-08-21T23:54:01.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":763,"price":84.97,"value":64832.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported $84.97 is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $84.90  to $85.02 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,296 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on November 20, 2025. 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates."}],"balance_after":21483,"source":{"system":"sec-edgar","filing":"0000950170-25-110761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017025110761/ownership.xml","form_type":"4"}},{"id":1069425,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2025-08-13T01:00:07.000Z","date":"2025-08-11","kind":"sale","planned":false,"acquired":false,"shares":1792,"price":86.57,"value":155133.44,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964\nshares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on\nMarch 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates."}],"balance_after":22246,"source":{"system":"sec-edgar","filing":"0000950170-25-107551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017025107551/ownership.xml","form_type":"4"}},{"id":1138194,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2025-05-22T20:30:38.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":530,"price":78.08,"value":41382.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average price ($78.08) . The shares were sold in multiple transactions at prices ranging from $77.83 to $78.35 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates."}],"balance_after":17244,"source":{"system":"sec-edgar","filing":"0000950170-25-076382","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017025076382/ownership.xml","form_type":"4"}},{"id":1218425,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2025-03-08T01:30:06.000Z","date":"2025-03-07","kind":"sale","planned":false,"acquired":false,"shares":1730,"price":82.11,"value":142050.3,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All 1,730 shares were sold at the same price of $82.11."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All 1,730 shares were sold at the same price of $82.11."}],"balance_after":7168,"source":{"system":"sec-edgar","filing":"0000950170-25-035831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017025035831/ownership.xml","form_type":"4"}},{"id":1244320,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2025-02-27T01:00:04.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments of 506 shares vesting on each of May 20, August 20, November 20 and March 6 in each year 2025, 2026, 2027 and 2028, with the final 510 shares vesting on March 6, 2029, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the shares noted in footnote 1 and 11,092, shares described in next sentences. On February 24, 2025, the issuer and the reporting person mutually agreed to amend the vesting terms of the outstanding awards. Per the amendment, of the total outstanding unvested shares of 11,092, 1,442 will vest on May 20, 2025, August 20, 2025 and November 20, 2025, 1,458 will vest on March 6, 2026, 818 will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 826 will vest on March 6, 2027, 506 will vest on each of May 20, 2027, August 20, 2027, November 2027 and 510 will vest on March 6, 2028, if he is employed on those dates."}],"balance_after":19192,"source":{"system":"sec-edgar","filing":"0000950170-25-028166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017025028166/ownership.xml","form_type":"4"}},{"id":1369954,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2024-11-12T23:00:07.000Z","date":"2024-11-08","kind":"sale","planned":false,"acquired":false,"shares":1724,"price":96.29,"value":166003.96,"ownership":{"direct":false,"nature":"Reeve Trust"},"balance_after":7106,"source":{"system":"sec-edgar","filing":"0000950170-24-125739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024125739/ownership.xml","form_type":"4"}},{"id":1426904,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2024-08-21T21:49:51.000Z","date":"2024-08-21","kind":"sale","planned":false,"acquired":false,"shares":1724,"price":82.5,"value":142230.0,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is the weighted average price. The reporting person undertakes to provide to U.S. Physical Therapy Inc., any of its shareholders or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold each at each separate price on this footnote Form 4."}],"balance_after":7038,"source":{"system":"sec-edgar","filing":"0000950170-24-099579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024099579/ownership.xml","form_type":"4"}},{"id":1518253,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2024-05-14T22:15:21.000Z","date":"2024-05-10","kind":"sale","planned":false,"acquired":false,"shares":1724,"price":105.46,"value":181813.04,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported ($105.46) is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $105.44 to $105.50 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":6970,"source":{"system":"sec-edgar","filing":"0000950170-24-059850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024059850/ownership.xml","form_type":"4"}},{"id":1599640,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2024-03-05T23:28:06.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":2629,"price":104.39,"value":274441.31,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $104.12 to $104.74 per share, both inclusive.  The reporting person undertakes to provide U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set fort in this footnote to this Form 4."}],"balance_after":6902,"source":{"system":"sec-edgar","filing":"0000950170-24-026491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024026491/ownership.xml","form_type":"4"}},{"id":1613511,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2024-02-29T01:26:47.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 8,100 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 506 shares vesting on April 1, 2024 thereafter 506 shares on April 1, July 1, October 1 and January 1 of each year with the final 510 shares lapsong on Janaury 1, 2028 if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,260 shares, inclusive of those shares mentioned in note1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,792 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 1,793 shares on January 1, 2025; 1,442 shares on each of April 1, 2025, July 1, 2025, October 1, 2025; 1,459 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on  January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates."}],"balance_after":18260,"source":{"system":"sec-edgar","filing":"0000950170-24-022520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024022520/ownership.xml","form_type":"4"}},{"id":1739797,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2023-11-16T22:42:59.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":87.39,"value":131085.0,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.02 to $87.54, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":7801,"source":{"system":"sec-edgar","filing":"0001209191-23-055567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919123055567/doc4.xml","form_type":"4"}},{"id":1809111,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2023-08-14T20:59:18.000Z","date":"2023-08-11","kind":"sale","planned":false,"acquired":false,"shares":4114,"price":109.99,"value":452498.86,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.27 to $111.14, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":7577,"source":{"system":"sec-edgar","filing":"0001209191-23-045664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919123045664/doc4.xml","form_type":"4"}},{"id":1970215,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2023-03-06T21:11:13.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":1912,"price":100.95,"value":193016.4,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.73 to $101.00, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":8243,"source":{"system":"sec-edgar","filing":"0001209191-23-016252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919123016252/doc4.xml","form_type":"4"}},{"id":1997209,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2023-02-23T21:37:07.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 5,000 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 quarterly installments with 312 shares vesting on the first day of each of the succeeding fifteen quarters beginning on April 1, 2023, and with the final 320 shares vesting on January 1, 2027, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 17,062 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse as to 1,724 shares on each of April 1, 2023, July 1, 2023, October 1, 2023; 1,730 shares on January 1, 2024; 1,286 shares on each of April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025; 936 shares on each of April 1, 2025 July 1, 2025 and October 1, 2025; 952 shares on January 1, 2026; and 312 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates."}],"balance_after":17062,"source":{"system":"sec-edgar","filing":"0001209191-23-012208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919123012208/doc4.xml","form_type":"4"}},{"id":2122777,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2022-11-08T21:47:09.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":1909,"price":84.79,"value":161864.11,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price $84.79 The shares were purchased in multiple transactions at prices ranging from $84.55 to $85.00 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":8083,"source":{"system":"sec-edgar","filing":"0001209191-22-056112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919122056112/doc4.xml","form_type":"4"}},{"id":2190086,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2022-08-10T16:36:10.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":3818,"price":92.24,"value":352172.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.12 to $92.50 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,191 shares which restrictions lapse as to 2,057 shares on October 1, 2022; 2,072 shares on January 1, 2023; 1,412 shares on each of April 1, July 1, and October 1, 2023; 1,418 shares on January 1, 2024; and 974 shares on each of April 1, July 1, and October 1, 2024; 974 shares on January 1, 2025; and 624 shares on April 1, July 1, October 1, 2025 with the final  640 shares lapsing on January 1, 2026 if he is still employed by the Company on those dates."}],"balance_after":16191,"source":{"system":"sec-edgar","filing":"0001209191-22-045144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919122045144/doc4.xml","form_type":"4"}},{"id":2334309,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2022-03-15T14:00:53.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 15 equal quarterly installments with the first 624 shares on April 1, 2022 and thereafter with 624 shares on April 1, July 1, October 1 and January 1 of each year with the final 640 shares lapsing on January 1, 2026, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 10,000 shares in Footnote 1 and includes 10,305 shares which restrictions lapse as to 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2024 and January 1, 2025, if he is employed by the Company on those dates.  Also includes 7,639 shares held in a trust in which Mr. Reeve is trustee and beneficiary."}],"balance_after":20305,"source":{"system":"sec-edgar","filing":"0001209191-22-018694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919122018694/doc4.xml","form_type":"4"}},{"id":2362730,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common StockCommon Stock","published_at":"2022-03-02T16:22:46.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":2118,"price":90.75,"value":192208.5,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.68 - $91.11, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":7639,"source":{"system":"sec-edgar","filing":"0001209191-22-014493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919122014493/doc4.xml","form_type":"4"}},{"id":2483068,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2021-12-07T15:42:20.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":1000,"price":94.19,"value":94190.0,"ownership":{"direct":false,"nature":"Reeve trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.00 to $94.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":7845,"source":{"system":"sec-edgar","filing":"0001209191-21-068262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121068262/doc4.xml","form_type":"4"}},{"id":2609162,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2021-08-10T22:23:00.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":1559,"price":114.15,"value":177959.85,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price ($114.15).  The shares were sold in multiple transactions at prices ranging from $113.96 to $114.42 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":6936,"source":{"system":"sec-edgar","filing":"0001209191-21-050678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121050678/doc4.xml","form_type":"4"}},{"id":2721748,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2021-05-10T16:56:17.000Z","date":"2021-05-07","kind":"sale","acquired":false,"shares":1819,"price":117.99,"value":214623.81,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price ($117.99).  The shares were sold in multiple transactions at prices ranging from $117.97 to $118.20 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":6586,"source":{"system":"sec-edgar","filing":"0001209191-21-031177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121031177/doc4.xml","form_type":"4"}},{"id":2822939,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2021-03-02T17:05:46.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1200,"price":116.5,"value":139800.0,"ownership":{"direct":false,"nature":"Reeve Trust"},"balance_after":6496,"source":{"system":"sec-edgar","filing":"0001209191-21-015607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121015607/doc4.xml","form_type":"4"}},{"id":2837081,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2021-02-24T17:12:26.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The  5,600 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan of which 4,400 under the Companys Discretionary Long-Term Incentive Plan for Senior Management and 1,200 as an additional grant.  Restrictions lapse in 16 equal quarterly installment with the first 350 shares on April 1, 2021 and thereafter with 350 shares on April 1, July 1, October 1 and January 1 of each year with the final 350 shares lapsing on January 1, 2025, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Inclusive of the above 5,600 shares in footnote 1, includes 17, 944 shares which restrictions lapse as to 1,909 shares on each of April 1, July 1 and October 1, 2021; 1,912 shares on January 1, 2022; 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates."}],"balance_after":17944,"source":{"system":"sec-edgar","filing":"0001209191-21-013678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121013678/doc4.xml","form_type":"4"}},{"id":2982011,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2020-11-13T15:11:59.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":1000,"price":104.23,"value":104230.0,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.86 to $104.59, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Shares are held in the Reeve Living Trust which Mr. Reeve is a trustee and beneficiary."}],"balance_after":6137,"source":{"system":"sec-edgar","filing":"0001209191-20-058216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120058216/doc4.xml","form_type":"4"}},{"id":3057789,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2020-08-14T18:29:12.000Z","date":"2020-08-12","kind":"sale","acquired":false,"shares":1500,"price":90.21,"value":135315.0,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares are held in the Reeve Living Trust which Mr. Reeve is a trustee and beneficiary."}],"balance_after":5578,"source":{"system":"sec-edgar","filing":"0001209191-20-046749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120046749/doc4.xml","form_type":"4"}},{"id":3129712,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2020-06-01T22:03:05.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":1000,"price":78.35,"value":78350.0,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares are held in the Reeve Living Trust, which Mr. Reeve is a trustee and beneficiary."}],"balance_after":5519,"source":{"system":"sec-edgar","filing":"0001209191-20-033289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120033289/doc4.xml","form_type":"4"}},{"id":3225476,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2020-03-05T19:23:50.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":7014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 7,014 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installment with the 438 shares on April 1, 2020 and thereafter with 438 shares on April 1, July 1, October 1 and January 1 of each year with the final 444 shares lapsing on January 1, 2024, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,580 shares which restrictions lapse as to 1,559 shares on each of April 1, July 1 and October 1, 2020 and 2021; 1,562 shares on January 1, 2022; 1,083 shares on each of April 1, July 1 and October 1, 2022; 1,098 shares on January 1, 2023; 438 shares on each of April 1, July 1 and October 1 2023 and 444 shares on January 1, 2024, if he is employed by the Company on those dates."}],"balance_after":18580,"source":{"system":"sec-edgar","filing":"0001209191-20-016493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120016493/doc4.xml","form_type":"4"}},{"id":3360386,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2019-11-25T17:10:01.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":476,"price":116.06,"value":55244.56,"ownership":{"direct":false,"nature":"Reeve Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares are held in the Reeve Living Trust, which Mr. Reeve is a trustee and beneficiary."}],"balance_after":3839,"source":{"system":"sec-edgar","filing":"0001209191-19-057902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119057902/doc4.xml","form_type":"4"}},{"id":3440431,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2019-08-13T18:08:05.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":952,"price":134,"value":127568.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13,808 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 1,121 shares on each of October 1, 2019, January 1, April 1, July1, October 1, 2020 and 2021; 1,124 shares on each of January 1, 2022; 645 shares on each of April 1, July 1 and October 1, 2022; 660 shares on January 1, 2023."}],"balance_after":17002,"source":{"system":"sec-edgar","filing":"0001209191-19-045707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119045707/doc4.xml","form_type":"4"}},{"id":3615738,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2019-03-05T22:13:51.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":10335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,335 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installment with the 645 shares on April 1, 2019 and thereafter with 645 shares on April 1, July 1, October 1 and January 1 of each year with the final 660 shares lapsing on January 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,050 shares, inclusive of the 10,335 shares in footnote 1, of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 1,121 shares on each of April 1, 2019, July 1, 2019, October 1, 2019, January 1, 2020, April 1, 2020, July 1, 2020, October 1, 2020, January 1, 2021, April 1, 2021, July 1, 2021 and October 1, 2021; and 1,124 shares on January 1, 2022; 645 on each of April 1, July 1 and October 1, 2022; and 660 on January 1, 2023."}],"balance_after":17954,"source":{"system":"sec-edgar","filing":"0001209191-19-016720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119016720/doc4.xml","form_type":"4"}},{"id":4009113,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":20564,"kind":"person","name":"REEVE GRAHAM D.","position":1,"cik":"0001519948","reported_name":"REEVE GRAHAM D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2018-03-07T19:46:28.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":7619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 7,619 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 quarterly installment with the first 15 installments of 476 shares each beginning on April 1, 2018 and thereafter with 476 shares on April 1, July 1, October 1 and January 1 of each year with the final 479 shares lapsing on January 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"See Note (1)."}],"balance_after":7619,"source":{"system":"sec-edgar","filing":"0001209191-18-017654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118017654/doc4.xml","form_type":"4"}}]}